Tela Bio
TELA Micro CapHealthcare · Medical Devices
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Tela Bio en bref
Tela Bio (TELA) is currently trading at 0,70 € with a market capitalization of 31 M €. The 52-week range spans from 0,44 € to 1,92 €; the current price is 63.6% below the yearly high. Year-over-year revenue growth stands at +2.9%.
💰 Dividende
Tela Bio currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
5 analystes évaluent Tela Bio (TELA) au consensus : None. L'objectif de cours moyen est de 1,96 €, soit un potentiel de +180.9% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 0,87 € à 2,83 €.
Tela Bio : la thèse d'investissement en détail
Tela Bio (TELA) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
With a gross margin near 67.72%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.
Le scénario baissier
Revenue growth has slowed to just 2.9%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.
À surveiller
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 180.9% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 67.72% — signe d'un pouvoir de fixation des prix
- –Actuellement non rentable
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Tela Bio?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news